The purchasing from India will follow the arrival of the free Covishield vaccine Thursday, which will be accepted by President Rajapaksa at the Colombo airport.
The lack of regulatory clarity coupled with lack of transparency from CDSCO raises questions on the safety and efficacy of the Covid-19 vaccine candidates.
As India gears up to roll out a national vaccination programme, Bharat Biotech and Serum Institute's barbs at each other will only add to vaccine hesitancy.
Dr A K Abdul Momen said that the first consignment of the vaccine co-manufactured by India's Serum Institute is expected to reach Bangladesh towards the end of January.
Bharat Biotech MD Dr Krishna Ella says they gave ‘excellent safety data tested on around 25,000 participants’ & their efficacy data will be available by February-March.
Officials have 'indicated orally' that first 100mn vaccines will be purchased at Rs 200 & a deal should be inked 'in next one or two days', according to Serum CEO Adar Poonawalla.
The UK government has ordered 100 million doses of the Oxford vaccine and scientific advisers have calculated that at least 2 million vaccinations a week could be needed.
Many of the corporate crises were self-inflicted. As in years past, executives often failed to apply the most basic principles of crisis and reputation management.
Countering insurgency needs the Pakistan Army to demonstrate a political will that ties leaders at the centre with those in the borderlands. But it may not have the imagination.
Centre for Science and Environment in new report makes case for rationalising GST on waste material, saying most informal operators can’t afford high tax & it also hinders recycling.
21st edition of annual joint military exercise will be held from 1 to 16 September, aimed at sharing military tech, operational best practices & disaster relief coordination methods.
Standing up to America is usually not a personal risk for a leader in India. Any suggestions of foreign pressure unites India behind who they see as leading them in that fight.
COMMENTS